Fosun's $1.5b biotech arm said to be considering Hong Kong IPO

Fosun's $1.5b biotech arm said to be considering Hong Kong IPO

02 February, 2018

Fosun Group fosun pharma Henlius Biotech Shanghai Henlius Biotech Inc.

Printed by Unregistered user on Sat, 20 Dec 2025 07:12:01 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

Read more from Greater China

Chinese humanoid robot developer Galbot raises $300m at $3b valuation

‘Singapore washing’ gains pace as Chinese firms relocate to city-state